NF-Kβ Activation in U266 Cells on Mesenchymal Stem Cells

Area of Science:

• Hematology
• Cell Biology
• Cancer Research

Background:

• Mesenchymal Stem Cells (MSCs) are key components of the bone marrow microenvironment.
• Multiple Myeloma (MM) is a significant hematological malignancy.
• MSCs influence MM cells, notably through the NF-κB signaling pathway, which is crucial for MM cell survival and drug resistance.

Purpose of the Study:

• To investigate the interaction between U266 MM cells and Umbilical Cord Blood-derived MSCs (UCB-MSCs).
• To determine the effect of UCB-MSCs on MM cell proliferation, CD54 expression, and key signaling pathways.

Main Methods:

• U266 cells were co-cultured with UCB-MSCs or their conditioned medium.
• Proliferation was assessed using MTT assay.
• CD54 expression was measured by flow cytometry.
• Gene expression (CXCL1, CCL4, IL-6, IL-8) and NF-κB pathway activation (p65 phosphorylation) were analyzed via RT-PCR and Western blotting.

Main Results:

• UCB-MSCs significantly increased U266 cell proliferation and CD54 expression.
• UCB-MSCs altered the expression of CCL4, IL-6, IL-8, and CXCL1 in U266 cells.
• Phosphorylation of p65 in the NF-κB pathway was elevated in U266 cells upon interaction with UCB-MSCs.

Conclusions:

• UCB-MSCs support MM cell proliferation and modulate immune markers.
• MSCs activate the NF-κB signaling pathway in MM cells.
• Targeting the NF-κB pathway presents a potential therapeutic strategy for MM.